Vicor's AI Power Story Intact, But Valuation and Execution Risks Persist

What happened

Vicor's latest report confirms the AI power-delivery boom is translating into tangible results, with Q2 2026 revenue up 26.9% sequentially to $143.4M, gross margin improving to 58%, and backlog ballooning to $380M from $176.9M at year-end 2025. The Zacks article highlights surging Advanced Products revenues and royalties, which reached $30.4M in Q2, as evidence that the company's high-density power solutions are gaining traction with hyperscalers. However, the master report cautions that this strength is already priced in, as the stock trades at 70.9x earnings and 80.9x EV/EBITDA, leaving little margin for error. Management remains capacity constrained, with the first ChiP fab fully absorbed and no committed timetable for a second fab, which could cap shipment growth despite robust demand. Meanwhile, royalty revenue is usage-based and lumpy, and customer concentration is rising, with one customer representing 11.1% of 2025 revenue, adding execution risk to the otherwise strong narrative.

Implication

The current price of $214.7 is not attractive for new purchases, as it capitalizes durable royalties, clean backlog conversion, and timely capacity expansion that have not yet been proven. A pullback toward the $175 area would offer a better risk-reward, especially if Q3 royalty revenue holds above $25M and backlog remains above $350M. Key triggers for reassessment are a committed second-fab timetable, sustained royalty durability, and the start of the lead-customer 2nd Gen VPD ramp before December 2026. Failure to deliver on these milestones could lead to a sharp de-rating, as the market currently prices in flawless execution. Therefore, hold existing positions but avoid adding until either the valuation normalizes or the company provides concrete evidence of capacity expansion and revenue durability.

Thesis delta

The new article does not materially alter the investment thesis. It reinforces the positive demand and backlog trends already captured in the master report, but it also does not address the critical risks of lumpy royalties, capacity constraints, and stretched valuation. Consequently, the WAIT rating and $175 attractive entry remain appropriate.